Literature DB >> 2785572

The cell cycle block and lysis of an activated T cell hybridoma are distinct processes with different Ca2+ requirements and sensitivity to cyclosporine A.

M Merćep1, P D Noguchi, J D Ashwell.   

Abstract

Stimulation of transformed T cells leads to both lymphokine secretion and inhibition of spontaneous growth. Studies performed with an Ag-specific T cell hybridoma demonstrated that growth inhibition is an early (within 1 h) manifestation of activation. Experiment in which extracellular Ca2+ was chelated or in which cyclosporine A was included indicated that activation-associated growth inhibition is a two-step process. The first phase is the establishment of a G1/S cell cycle block; it does not require extracellular Ca2+ and is not prevented by the addition of cyclosporine A. The second phase is cell lysis. It can be detected 4 to 6 h after activation, requires the presence of extracellular Ca2+, and is prevented when stimulation occurs in the presence of cyclosporine A. The observation that both Ca2+ depletion and cyclosporine A prevented IL-2 secretion at all time points indicates that the pathways leading to lymphokine secretion and the G1/S block diverge early in the course of the cellular response, and establish the cell cycle block as a distinct activation event with unique characteristics.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785572

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Susceptibility to cell death is a dominant phenotype: triggering of activation-driven T-cell death independent of the T-cell antigen receptor complex.

Authors:  G Nickas; J Meyers; L D Hebshi; J D Ashwell; D P Gold; B Sydora; D S Ucker
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

2.  Receptor-stimulated death pathway is opened by antigen in mature T cells.

Authors:  J H Russell; C L White; D Y Loh; P Meleedy-Rey
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

3.  Pharmacological inhibition of protein kinase C activity could induce apoptosis in gastric cancer cells by differential regulation of apoptosis-related genes.

Authors:  G H Zhu; B C Wong; M C Eggo; S T Yuen; K C Lai; S K Lam
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

4.  A major human immunodeficiency virus type 1-initiated killing pathway distinct from apoptosis.

Authors:  V Kolesnitchenko; L King; A Riva; Y Tani; S J Korsmeyer; D I Cohen
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Protease inhibitors selectively block T cell receptor-triggered programmed cell death in a murine T cell hybridoma and activated peripheral T cells.

Authors:  A Sarin; D H Adams; P A Henkart
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

6.  Activation-induced T-cell death is cell cycle dependent and regulated by cyclin B.

Authors:  R Fotedar; J Flatt; S Gupta; R L Margolis; P Fitzgerald; H Messier; A Fotedar
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

7.  Involvement of LFA-1/ICAM-2 adhesive interactions and PKC in activation-induced cell death following SEB rechallenge.

Authors:  E Z Tchilian; G Anderson; N C Moore; J J Owen; E J Jenkinson
Journal:  Immunology       Date:  1996-04       Impact factor: 7.397

8.  Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.

Authors:  B E Bierer; P S Mattila; R F Standaert; L A Herzenberg; S J Burakoff; G Crabtree; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

9.  9-cis-retinoic acid inhibits activation-driven T-cell apoptosis: implications for retinoid X receptor involvement in thymocyte development.

Authors:  Y Yang; M S Vacchio; J D Ashwell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

10.  Human immunodeficiency virus 1 envelope-initiated G2-phase programmed cell death.

Authors:  V Kolesnitchenko; L M Wahl; H Tian; I Sunila; Y Tani; D P Hartmann; J Cossman; M Raffeld; J Orenstein; L E Samelson; D I Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.